Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Model averaging inconcentration-QT analyses.
Sébastien B, Hoffman D, Rigaux C, Pellissier F, Msihid J. Sébastien B, et al. Among authors: msihid j. Pharm Stat. 2016 Nov;15(6):450-458. doi: 10.1002/pst.1766. Epub 2016 Aug 5. Pharm Stat. 2016. PMID: 27492846
Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY.
Boyapati A, Msihid J, Fiore S, van Adelsberg J, Graham NM, Hamilton JD. Boyapati A, et al. Among authors: msihid j. Arthritis Res Ther. 2016 Oct 6;18(1):225. doi: 10.1186/s13075-016-1132-9. Arthritis Res Ther. 2016. PMID: 27716324 Free PMC article. Clinical Trial.
Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes.
Gabay C, Burmester GR, Strand V, Msihid J, Zilberstein M, Kimura T, van Hoogstraten H, Boklage SH, Sadeh J, Graham NMH, Boyapati A. Gabay C, et al. Among authors: msihid j. Arthritis Res Ther. 2020 Apr 7;22(1):70. doi: 10.1186/s13075-020-02163-6. Arthritis Res Ther. 2020. PMID: 32264972 Free PMC article. Clinical Trial.
Association of High Serum Interleukin-6 Levels With Severe Progression of Rheumatoid Arthritis and Increased Treatment Response Differentiating Sarilumab From Adalimumab or Methotrexate in a Post Hoc Analysis.
Boyapati A, Schwartzman S, Msihid J, Choy E, Genovese MC, Burmester GR, Lam G, Kimura T, Sadeh J, Weinreich DM, Yancopoulos GD, Graham NMH. Boyapati A, et al. Among authors: msihid j. Arthritis Rheumatol. 2020 Sep;72(9):1456-1466. doi: 10.1002/art.41299. Epub 2020 Aug 25. Arthritis Rheumatol. 2020. PMID: 32343882 Free PMC article.
Dupilumab reduces absenteeism in patients with moderate to severe atopic dermatitis: Pooled results from the LIBERTY AD SOLO clinical trials.
de Bruin-Weller M, Simpson EL, Cork M, Chen Z, Msihid J, Taniou C, Eckert L, Gadkari A, Bégo-Le Bagousse G. de Bruin-Weller M, et al. Among authors: msihid j. J Am Acad Dermatol. 2020 Nov;83(5):1499-1501. doi: 10.1016/j.jaad.2020.05.142. Epub 2020 Jun 3. J Am Acad Dermatol. 2020. PMID: 32504724 Free article. No abstract available.
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps.
Hopkins C, Wagenmann M, Bachert C, Desrosiers M, Han JK, Hellings PW, Lee SE, Msihid J, Radwan A, Rowe P, Amin N, Deniz Y, Ortiz B, Mannent LP, Rout R. Hopkins C, et al. Among authors: msihid j. Int Forum Allergy Rhinol. 2021 Jul;11(7):1087-1101. doi: 10.1002/alr.22780. Epub 2021 Feb 21. Int Forum Allergy Rhinol. 2021. PMID: 33611847 Free PMC article. Clinical Trial.
Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study.
Hopkins C, Buchheit KM, Heffler E, Cohen NA, Olze H, Khan AH, Msihid J, Siddiqui S, Nash S, Jacob-Nara JA, Rowe PJ, Deniz Y. Hopkins C, et al. Among authors: msihid j. J Asthma Allergy. 2022 Jun 7;15:767-773. doi: 10.2147/JAA.S363527. eCollection 2022. J Asthma Allergy. 2022. PMID: 35698581 Free PMC article.
43 results